As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: January 25, 2012
by SciTech Daily:
A new study has shown that skin cells harvested from patients with Alzheimer’s disease can be reprogrammed to form brain cells, offering clues to dementia and the prospect of early diagnosis as well as new treatments.
Alzheimer’s disease causes neurodegeneration and strikes late in life. However, the disease is almost impossible to diagnose before actual symptoms develop. Currently, there are no drugs in existence that can change the course of the disease.
By the time dementia is noticed in a patient, they’ve been suffering from it for years, even decades, states Larry Goldstein, neuroscientist at the University of California, San Diego, lead author of the study which was published in Nature.
The team created induced pluripotent stem (iPS) cells from four patients with Alzheimer’s and two from people without any dementia. The iPS cells were made by treating fibroblasts, a kind of skin cell, with reprogramming factors, allowing them to revert to an embryonic-like state. Just like stem cells from early embryos, iPS cells can form any tissue in the body, including neurons.
These reprogrammed neurons from patients with familial Alzheimer’s showed defects that had been seen before in the actual brains of Alzheimer’s patients, which allowed researchers to compare them to unaffected cells. These neurons produced higher levels of the protein amyloid-β, which forms plaques in patients with Alzheimer’s. The neurons also produced elevated amounts of the protein tau, which forms tangles in the brains of patients.
Other researchers have voiced concerns that these disease-in-a-dish models based on iPS cells may not reflect the real disease, but the discoveries might actually be artifacts of the reprogramming process. However, previous studies using different mutations have shown similar molecular defects as the ones in the Goldstein study. This suggests that the changes seen are actual ones instead of artifacts.
Such cells will help scientists develop new drugs and tailor them to individual patients, based on how their reprogrammed brain cell responded. They could also allow early Alzheimer’s diagnosis.
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
Foods can determine whether someone will suffer from dementia in later years, according to researchers at the Hebrew University of Jerusalem’s Faculty of Agriculture, Food and Environment in Rehovot. A large-scale international study that...
Taking care of someone with Alzheimer’s disease and other forms of dementia is not an easy task. Caregiving is a long-term endeavour that is mentally, emotionally, physically, and financially demanding, and is a role that...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.